Well Referenced

Tag: extracorporeal shockwave therapy

Comparison efficacy of ESWT and Wharton’s jelly mesenchymal stem cell in early osteoarthritis of rat knee

This 2019 preclinical study evaluated the therapeutic effects of extracorporeal shockwave therapy (ESWT), Wharton’s jelly-derived mesenchymal stem cells (WJMSCs), and their combination in a rat model of early knee osteoarthritis (KOA). All treatment modalities significantly improved cartilage integrity and subchondral bone remodeling, as evidenced by pathological assessments, micro-CT, and immunohistochemical

Read More »
June 26, 2025 No Comments

Shockwave Therapy Combined with Autologous Adipose-Derived Mesenchymal Stem Cells Is Better than with Human Umbilical Cord Wharton’s Jelly-Derived Mesenchymal Stem Cells on Knee Osteoarthritis

This 2020 preclinical study evaluated the efficacy of combining extracorporeal shockwave therapy (ESWT) with either autologous adipose-derived mesenchymal stem cells (ADMSCs) or human umbilical cord Wharton’s jelly-derived mesenchymal stem cells (WJMSCs) in treating early-stage knee osteoarthritis (KOA) in a rat model. The ESWT+ADMSCs group demonstrated superior outcomes, including increased trabecular

Read More »
June 26, 2025 No Comments

The efficacy and safety of extracorporeal shockwave therapy in knee osteoarthritis: A systematic review and meta-analysis

This 2020 systematic review and meta-analysis evaluated the efficacy and safety of extracorporeal shockwave therapy (ESWT) in treating knee osteoarthritis (KOA). Analyzing three randomized controlled trials and three cohort studies encompassing 589 patients, the study found that ESWT significantly reduced pain scores at 4, 8, and 12 weeks post-treatment, with

Read More »
June 26, 2025 No Comments

Extracorporeal Shockwave Therapy Combined with Drug Therapy in Chronic Pelvic Pain Syndrome: A Randomized Clinical Trial

This randomized clinical trial assessed the efficacy of combining extracorporeal shockwave therapy (ESWT) with pharmacotherapy in treating chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS). Thirty-one male patients were divided into two groups: the intervention group received a combination of an alpha-blocker, anti-inflammatory agent, muscle relaxant, a short course of antibiotics, and

Read More »
June 26, 2025 No Comments